Since you brought it up....Shebas program has flown a bit under the radar here in Tovaxin land, at least for me. How similar/different is their protocol? The question for me would be, if they are similar treatments wouldn't the obvious route for Tovaxanites be to ride that horse rather than resurrect Tovaxin?
Seems to me that the inclusion/exclusion criteria for this stuff would eliminate every MS patient that I've ever come across:
* Age: 15 - 50 years.
* Three months within the acute onset of neurological symptoms suggestive of the first attack of multiple sclerosis.
* Diagnosis of CPMS C3 (Poser criteria).
* Positive brain MRI according to Fazekas criteria.
* Negative pregnancy test and use of effective contraceptive for female patients who are sexually active.
* Signed written informed consent.
* Blood tests suggestive of other autoimmune diseases.
* Known allergic reactions to MRI contrast media.
* A clear regression of the neurological symptoms after the first attack that suggests a primary-progressive course.
* Corticosteroid treatment in the previous 4 weeks (28 days).
* Previous treatment with immunosuppressive medications such as cyclophosphamide, azathioprine, methotrexate, mitoxantrone or cyclosporine.
* Previous treatment with interferon beta 1a or 1b, copolymer-1, IVIg, plasmapheresis.